Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,979 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde PE, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Cordes J; COMBINE Study Group. Schmidt-Kraepelin C, et al. Among authors: lange c. Lancet Psychiatry. 2022 Apr;9(4):291-306. doi: 10.1016/S2215-0366(22)00032-3. Epub 2022 Mar 8. Lancet Psychiatry. 2022. PMID: 35276079 Clinical Trial.
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J. Schmidt-Kraepelin C, et al. Among authors: lange c. Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):83-94. doi: 10.1007/s00406-019-01063-4. Epub 2019 Sep 5. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31486890
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Schüpke S, et al. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475799 Clinical Trial.
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde PE, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Cordes J; COMBINE Study Group. Schmidt-Kraepelin C, et al. Among authors: lange c. Lancet Psychiatry. 2022 Apr;9(4):291-306. doi: 10.1016/S2215-0366(22)00032-3. Epub 2022 Mar 8. Lancet Psychiatry. 2022. PMID: 35276079 Clinical Trial.
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease.
Laville SM, Vendar J, Massy ZA, Gras-Champel V, Moragny J, Frimat L, Laville M, Jacquelinet C, Pecoits-Filho R, Alencar De Pinho N, Hamroun A, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. Laville SM, et al. Clin Kidney J. 2024 Nov 18;18(1):sfae357. doi: 10.1093/ckj/sfae357. eCollection 2025 Jan. Clin Kidney J. 2024. PMID: 39781474 Free PMC article.
Prognostic factors for transplant-free survival in patients with secondary sclerosing cholangitis associated with critical illness.
Konstantis G, Moghadam DGL, Frey A, Nuruzade N, Schramm C, Gerges C, Lange CM, Schmidt H, Willuweit K, Kahraman A, Passenberg M, Rashidi-Alavijeh J. Konstantis G, et al. Among authors: lange cm. BMJ Open Gastroenterol. 2025 Jan 4;12(1):e001571. doi: 10.1136/bmjgast-2024-001571. BMJ Open Gastroenterol. 2025. PMID: 39755560 Free article.
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif.
Neumann M, Reimann M, Chesov D, Popa C, Dragomir A, Popescu O, Munteanu R, Hölscher A, Honeyborne I, Heyckendorf J, Lange C, Hölscher C, Kalsdorf B. Neumann M, et al. Among authors: lange c. J Infect. 2024 Dec 27;90(2):106399. doi: 10.1016/j.jinf.2024.106399. Online ahead of print. J Infect. 2024. PMID: 39733827 Free article.
2,979 results